Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
Greig
N H
NH
Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892.
Pei
X F
XF
Soncrant
T T
TT
Ingram
D K
DK
Brossi
A
A
D000544:Alzheimer Disease / Q000188:drug therapy*; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D013329:Structure-Activity Relationship
D002800:Cholinesterase Inhibitors; C092643:physovenine; D010830:Physostigmine; C092280:phenserine